Chai, AdvanCell each draw $315M+ megarounds: Venture Report

AI design platform Chai Discovery and radiopharma company AdvanCell each closed $315 million-plus venture rounds this week, the latest additions to this year’s run of megarounds.

Chai Discovery Inc. led the week with a $400 million series C led by Index Ventures, valuing the two-year-old platform company at $3.8 billion. Its newest model, Chai-3, designs antibodies from scratch to optimize binding and developability, create multispecific formats, and address hard-to-drug targets...